Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Abbott and other ETFs, options, and stocks.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
114,000
Employees114,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
114,000
Employees114,000

ABT Key Statistics

Market cap
211.33B
Market cap211.33B
Price-Earnings ratio
15.36
Price-Earnings ratio15.36
Dividend yield
1.87%
Dividend yield1.87%
Average volume
6.35M
Average volume6.35M
High today
$121.92
High today$121.92
Low today
$117.78
Low today$117.78
Open price
$118.02
Open price$118.02
Volume
5.88M
Volume5.88M
52 Week high
$121.92
52 Week high$121.92
52 Week low
$99.71
52 Week low$99.71

ABT News

TipRanks 6h
Abbott price target raised to $135 from $130 at Stifel

Stifel raised the firm’s price target on Abbott (ABT) to $135 from $130 and keeps a Buy rating on the shares. The firm views Abbott’s Q4 results and the 2025 se...

TipRanks 8h
Abbott price target raised to $148 from $146 at UBS, shares remain undervalued

UBS raised the firm’s price target on Abbott (ABT) to $148 from $146 and keeps a Buy rating on the shares. Abbott’s quarterly results reinforced the firm’s conf...

Benzinga 23h
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Wednesday. The Dow traded up 0.27% to 44,146.86 whi...

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

Analyst ratings

70%

of 30 ratings
Buy
70%
Hold
30%
Sell
0%

More ABT News

CNBC 24h
Abbott shares climb despite a mixed quarter. What we want to see before we buy more

Club holding Abbott Laboratories on Wednesday reported mixed fourth-quarter results and 2025 guidance. Still, shares of the medical device maker are up more tha...

Abbott shares climb despite a mixed quarter. What we want to see before we buy more
TipRanks 1d
ABT Earnings: Abbott Posts Mixed Q4 Results, Issues FY25 Growth Outlook

Shares of Abbott (ABT) gained in trading after the company reported mixed results. The medical devices company’s adjusted earnings increased 12.6% year-over-yea...

Investor's Business Daily 1d
Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit

Abbott stock fell early Wednesday after the health giant narrowly missed fourth-quarter sales views and reported in-line profit. View comments...

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit
Barron's 1d
Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates

Abbott Laboratories posts total worldwide sales of $10.97 billion for the quarter ended Dec. 31, missing Wall Street estimates of $11.03 billion. View comments...

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates
Seeking Alpha 1d
Abbott Laboratories slips after Q4 topline miss

Abbott Laboratories (NYSE:ABT) traded ~2% lower in the premarket on Wednesday after the diagnostics company's Q4 2024 results fell short of Street forecasts for...

Abbott Laboratories slips after Q4 topline miss
Benzinga 1d
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Abb...

Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.